Association between parathyroid hormone levels and inflammatory markers among US adults

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Cheng, Shih Ping ^a,b,c   Liu, Chien Liang ^a,b   Liu, Tsang Pai ^a,b   Hsu, Yi Chiung ^d   Lee, Jie Jen ^a,b,c  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d INSTITUTE OF STATISTICAL SCIENCE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; PARATHYROID HORMONE;

ADULT; AGED; BLOOD; CROSS-SECTIONAL STUDY; CYTOLOGY; EPIDEMIOLOGY; ERYTHROCYTE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INFLAMMATION; LEUKOCYTE; MALE; METABOLISM; MIDDLE AGED; NUTRITION; RISK; STATISTICAL MODEL; UNITED STATES;

ADULT; AGED; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; ERYTHROCYTES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INFLAMMATION; LEUKOCYTES; LINEAR MODELS; MALE; MIDDLE AGED; NUTRITION SURVEYS; ODDS RATIO; PARATHYROID HORMONE; UNITED STATES;

EID: 84899444237     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/709024     Document Type: Article

References (51)

1. Silver J., Rodriguez M., Slatopolsky E., FGF23 and PTH-double agents at the heart of CKD. Nephrology Dialysis Transplantation 2012 27 1715 1720
2. Kritchevsky S. B., Tooze J. A., Neiberg R. H., Health ABC Study. 25-Hydroxyvitamin D, parathyroid hormone, and mortality in black and white older adults: the health ABC study. Journal of Clinical Endocrinology & Metabolism 2012 97 4156 4165
3. van Ballegooijen A. J., Reinders I., Visser M., Serum parathyroid hormone in relation to all-cause and cardiovascular mortality: the Hoorn study. Journal of Clinical Endocrinology & Metabolism 2013 98 E638 E645
4. Chen J. S., Sambrook P. N., March L., Cameron I. D., Cumming R. G., Simpson J. M., Seibel M. J., Hypovitaminosis D and parathyroid hormone response in the elderly: effects on bone turnover and mortality. Clinical Endocrinology 2008 68 2 290 298 2-s2.0-38049173584 10.1111/j.1365-2265.2007.03040.x
5. Gandhi S., Myers R. B., Can parathyroid hormone be used as a biomarker for heart failure? Heart Failure Reviews 2013 18 465 473
6. Lowik C. W. G. M., van der Pluijm G., Bloys H., Hoekman K., Bijvoet O. L. M., Aarden L. A., Papapoulos S. E., Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: a possible role of interleukin-6 in osteoclastogenesis. Biochemical and Biophysical Research Communications 1989 162 3 1546 1552 2-s2.0-0024404268 (Pubitemid 19214760)
7. Mitnick M. A., Grey A., Masiukiewicz U., Bartkiewicz M., Rios-Velez L., Friedman S., Xu L., Horowitz M. C., Insogna K., Parathyroid hormone induces hepatic production of bioactive interleukin-6 and its soluble receptor. American Journal of Physiology: Endocrinology and Metabolism 2001 280 3 E405 E412 2-s2.0-0035008661
8. Castell J. V., Gomez-Lechon M. J., David M., Andus T., Geiger T., Trullenque R., Fabra R., Heinrich P. C., Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Letters 1989 242 2 237 239 2-s2.0-0024581491 10.1016/0014-5793(89)80476-4 (Pubitemid 19020112)
9. Castell J. V., Gomez-Lechon M. J., David M., Fabra R., Trullenque R., Heinrich P. C., Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology 1990 12 5 1179 1186 2-s2.0-0025228036 10.1002/hep.1840120517
10. McCarty M. F., Secondary hyperparathyroidism promotes the acute phase response-a rationale for supplemental Vitamin D in prevention of vascular events in the elderly. Medical Hypotheses 2005 64 5 1022 1026 2-s2.0-15244355896 10.1016/j.mehy.2004.03.041 (Pubitemid 40385963)
11. Grey A., Mitnick M.-A., Shapses S., Ellison A., Gundberg C., Insogna K., Circulating levels of interleukin-6 and tumor necrosis factor-are elevated in primary hyperparathyroidism and correlate with markers of bone resorption-a clinical research center study. Journal of Clinical Endocrinology and Metabolism 1996 81 10 3450 3454 2-s2.0-0029798816 10.1210/jc.81.10.3450 (Pubitemid 26339897)
12. Guo C.-Y., Holland P. A., Jackson B. F., Hannon R. A., Rogers A., Harrison B. J., Eastell R., Immediate changes in biochemical markers of bone turnover and circulating interleukin-6 after parathyroidectomy for primary hyperparathyroidism. European Journal of Endocrinology 2000 142 5 451 459 2-s2.0-0034119794 (Pubitemid 30341175)
13. Øgard C. G., Engelmann M. D., Kistorp C., Nielsen S. L., Vestergaard H., Increased plasma N-terminal pro-B-type natriuretic peptide and markers of inflammation related to atherosclerosis in patients with primary hyperparathyroidism. Clinical Endocrinology 2005 63 5 493 498 2-s2.0-27744564076 10.1111/j.1365-2265.2005.02363.x (Pubitemid 41626742)
14. Emam A. A., Mousa S. G., Ahmed K. Y., Al-Azab A. A., Inflammatory biomarkers in patients with asymptomatic primary hyperparathyroidism. Medical Principles and Practice 2012 21 3 249 253 2-s2.0-84859619812 10.1159/000334588
15. Chertok-Shacham E., Ishay A., Lavi I., Luboshitzky R., Biomarkers of hypercoagulability and inflammation in primary hyperparathyroidism. Medical Science Monitor 2008 14 12 CR628 CR632 2-s2.0-57349126385
16. Farahnak P., Lärfars G., Sten-Linder M., Nilsson I.-L., Mild primary hyperparathyroidism: vitamin D deficiency and cardiovascular risk markers. Journal of Clinical Endocrinology and Metabolism 2011 96 7 2112 2118 2-s2.0-79960107705 10.1210/jc.2011-0238
17. Halabe A., Shohat B., Effect of parathyroid adenoma excision on interleukin-6 (IL-6) and IL-2 receptor levels. Metabolism: Clinical and Experimental 2000 49 2 192 194 2-s2.0-0033965360 (Pubitemid 30090882)
18. Almqvist E. G., Bondeson A.-G., Bondeson L., Svensson J., Increased markers of inflammation and endothelial dysfunction in patients with mild primary hyperparathyroidism. Scandinavian Journal of Clinical and Laboratory Investigation 2011 71 2 139 144 2-s2.0-79952376334 10.3109/00365513.2010.543694
19. Bollerslev J., Rosen T., Mollerup C. L., Nordenström J., Baranowski M., Franco C., Pernow Y., Isaksen G. A., Godang K., Ueland T., Jansson S., Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 2009 94 7 2255 2261 2-s2.0-67650242225 10.1210/jc.2008-2742
20. Zhao G., Ford E. S., Li C., Kris-Etherton P. M., Etherton T. D., Balluz L. S., Independent associations of serum concentrations of 25-hydroxyvitamin D and parathyroid hormone with blood pressure among US adults. Journal of Hypertension 2010 28 9 1821 1828 2-s2.0-77955848394 10.1097/HJH.0b013e32833bc5b4
21. Liu C. L., Lee J. J., Liu T. P., Chang Y. C., Hsu Y. C., Cheng S. P., Blood neutrophil-to-lymphocyte ratio correlates with tumor size in patients with differentiated thyroid cancer. Journal of Surgical Oncology 2013 107 493 497
22. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey 2003-2004, http://wwwn.cdc.gov/nchs/nhanes/search/nhanes03- 04.aspx
23. Centers for Disease Control, Prevention,. National Health and Nutrition Examination Survey 2005-2006, http://wwwn.cdc.gov/nchs/nhanes/search/nhanes05- 06.aspx
24. Levey A. S., Stevens L. A., Schmid C. H., CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Annals of Internal Medicine 2009 150 604 612
25. McMillan D. C., The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treatment Reviews 2013 39 534 540
26. Rodriguez M., Lorenzo V., Parathyroid hormone, a uremic toxin. Seminars in Dialysis 2009 22 4 363 368 2-s2.0-69249103730 10.1111/j.1525-139X.2009.00581. x
27. Cheng S. P., Lee J. J., Liu T. P., Parathyroidectomy improves symptomatology and quality of life in patients with secondary hyperparathyroidism. Surgery 2014 155 320 328
28. Hagström E., Hellman P., Larsson T. E., Ingelsson E., Berglund L., Sundström J., Melhus H., Held C., Lind L., Michaëlsson K., Ärnlöv J., Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 2009 119 21 2765 2771 2-s2.0-67649223663 10.1161/CIRCULATIONAHA.108.808733
29. Cawthon P. M., Parimi N., Barrett-Connor E., Laughlin G. A., Ensrud K. E., Hoffman A. R., Shikany J. M., Cauley J. A., Lane N. E., Bauer D. C., Orwoll E. S., Cummings S. R., Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men. Journal of Clinical Endocrinology and Metabolism 2010 95 10 4625 4634 2-s2.0-77957766969 10.1210/jc.2010-0638
30. Caron N. R., Pasieka J. L., What symptom improvement can be expected after operation for primary hyperparathyroidism? World Journal of Surgery 2009 33 11 2244 2255 2-s2.0-70350015162 10.1007/s00268-009-9987-4
31. Christensen M. H. E., Dankel S. N., Nordbø Y., Varhaug J. E., Almås B., Lien E. A., Mellgren G., Primary hyperparathyroidism influences the expression of inflammatory and metabolic genes in adipose tissue. PLoS ONE 2011 6 6 2-s2.0-79959277578 10.1371/journal.pone.0020481 e20481
32. Lütfiolu M., Sakalliolu U., Sakalliolu E. E., Diraman E., Çiftçi G., Tutkun F., Dietary-induced hyperparathyroidism affects serum and gingival proinflammatory cytokine levels in rats. Journal of Periodontology 2010 81 1 150 157 2-s2.0-77649196561 10.1902/jop.2009.090353
33. Alemzadeh R., Kichler J., Parathyroid hormone is associated with biomarkers of insulin resistance and inflammation, independent of vitamin D status, in obese adolescents. Metabolic Syndrome and Related Disorders 2012 10 422 429
34. Hjelmesæth J., Hofsø D., Aasheim E. T., Jenssen T., Moan J., Hager H., Røislien J., Bollerslev J., Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study. Cardiovascular Diabetology 2009 8, article 7 2-s2.0-61349175930 10.1186/1475-2840-8-7
35. Yousuf O., Mohanty B. D., Martin S. S., High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link? Journal of the American College of Cardiology 2013 62 397 408
36. Allin K. H., Nordestgaard B. G., Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer. Critical Reviews in Clinical Laboratory Sciences 2011 48 4 155 170 2-s2.0-80155135586 10.3109/10408363.2011. 599831
37. Lippi G., Targher G., Montagnana M., Salvagno G. L., Zoppini G., Guidi G. C., Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Archives of Pathology & Laboratory Medicine 2009 133 628 632
38. Perlstein T. S., Weuve J., Pfeffer M. A., Beckman J. A., Red blood cell distribution width and mortality risk in a community-based prospective cohort. Archives of Internal Medicine 2009 169 6 588 594 2-s2.0-63849278012 10.1001/archinternmed.2009.55
39. Förhécz Z., Gombos T., Borgulya G., Pozsonyi Z., Prohászka Z., Jánoskuti L., Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. American Heart Journal 2009 158 4 659 666 2-s2.0-70349213219 10.1016/j.ahj.2009.07.024
40. Patel K. V., Semba R. D., Ferrucci L., Newman A. B., Fried L. P., Wallace R. B., Bandinelli S., Phillips C. S., Yu B., Connelly S., Shlipak M. G., Chaves P. H. M., Launer L. J., Ershler W. B., Harris T. B., Longo D. L., Guralnik J. M., Red Cell distribution width and mortality in older adults: a meta-analysis. Journals of Gerontology A: Biological Sciences and Medical Sciences 2010 65 3 258 265 2-s2.0-77949502698 10.1093/gerona/glp163
41. Klinger M. H. F., Jelkmann W., Role of blood platelets in infection and inflammation. Journal of Interferon and Cytokine Research 2002 22 9 913 922 2-s2.0-0036396275 10.1089/10799900260286623 (Pubitemid 35155690)
42. Smith R. A., Bosonnet L., Ghaneh P., Sutton R., Evans J., Healey P., Garvey C., Hughes M., Raraty M., Campbell F., Neoptolemos J. P., The platelet-lymphocyte ratio improves the predictive value of serum CA19-9 levels in determining patient selection for staging laparoscopy in suspected periampullary cancer. Surgery 2008 143 5 658 666 2-s2.0-43049141078 10.1016/j.surg.2007.12.014
43. Azab B., Shah N., Akerman M., McGinn J. T. Jr., Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction. Journal of Thrombosis and Thrombolysis 2012 34 326 334 2-s2.0-84858989884 10.1007/s11239-012-0718-6
44. Turkmen K., Erdur F. M., Ozcicek F., Platelet-to-lymphocyte ratio better predicts inflammation than neutrophil-to-lymphocyte ratio in end-stage renal disease patients. Hemodialysis International 2013 17 391 396
45. Benigni A., Livio M., Dodesini P., Inhibition of human platelet aggregation by parathyroid hormone. Is cyclic AMP implicated? American Journal of Nephrology 1985 5 4 243 247 2-s2.0-0022257001 (Pubitemid 15048605)
46. Fliser D., Franek E., Fode P., Stefanski A., Schmitt C. P., Lyons M., Ritz E., Subacute infusion of physiological doses of parathyroid hormone raises blood pressure in humans. Nephrology Dialysis Transplantation 1997 12 5 933 938 2-s2.0-0030988118 10.1093/ndt/12.5.933 (Pubitemid 27216313)
47. Geara A. S., Castellanos M. R., Bassil C., Schuller-Levis G., Park E., Smith M., Goldman M., Elsayegh S., Effects of parathyroid hormone on immune function. Clinical and Developmental Immunology 2010 2010 10 2-s2.0-77957860267 10.1155/2010/418695 418695
48. Proctor M. J., Morrison D. S., Talwar D., Balmer S. M., Fletcher C. D., O'reilly D. S. J., Foulis A. K., Horgan P. G., Mcmillan D. C., A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. European Journal of Cancer 2011 47 17 2633 2641 2-s2.0-80755128486 10.1016/j.ejca.2011.03.028
49. Munoz Mendoza J., Isakova T., Ricardo A. C., Chronic renal insufficiency cohort. Fibroblast growth factor 23 and Inflammation in CKD. Clinical Journal of the American Society of Nephrology 2012 7 1155 1162
50. Izquierdo M. C., Perez-Gomez M. V., Sanchez-Nino M. D., Klotho, phosphate and inflammation/ageing in chronic kidney disease. Nephrology Dialysis Transplantation 2012 27 supplement 4 iv6 i10
51. Kearns M. D., Alvarez J. A., Tangpricha V., Large, single-dose, oral vitamin D supplementation in adult populations: a systematic review. Endocrine Practice 18 1 36 10.4158/EP13265.RA